Figure 1.
![Figure 1. NY-ESO-1 gene expression. Gene expression profiling shows that NY-ESO-1 is expressed at increased frequency in patients with abnormal cytogenetics (a positive score is more than mean + 3 SD [90] of the GEP score of normal human PCs). SMM indicates smoldering MM.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/105/10/10.1182_blood-2004-09-3707/6/zh80100578580001.jpeg?Expires=1735534062&Signature=K0LS7qARE~LZWoasERLOrL6RH-wvuTUK9LeLkbfe-QcOwOY7jlMKyJFClzNEjFA-6coFW6i5T0T-2DExTojEolpBB6Aumu3uuJjB~ATtDEVkAExNXhIQnXOPNx~S7jIQ-qiWwOrC7ovOXSHoFeUHJ6epaXZjMft5fEhyGXxGlN1Em8EAVMgqLCg0PzAtFapYshtBW8wT6LCfVnD19cgVsSO12g7wAvjaz6OV~iknZZAJ6z~H3GlohEkiw0-7dnIuVTBu~xMY02vbpUrx4mEjS0RhhTluxE198hWjPtfKleJANbloCGFRJ3zTkXkoqw8RLu4cXiMbRjocKJQcrau8Fg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
NY-ESO-1 gene expression. Gene expression profiling shows that NY-ESO-1 is expressed at increased frequency in patients with abnormal cytogenetics (a positive score is more than mean + 3 SD [90] of the GEP score of normal human PCs). SMM indicates smoldering MM.
